Figure 5From: The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targetsSeveral strategies in the therapeutic considerations involving GH-IGF-SST system in the treatment of HCC. Dotted black arrows: activation by endogenous ligand. Black arrow: activation by exogenous ligand. Red lines: blocking of ligands and receptors.Back to article page